Holen Sie sich die Stockscreener-App
687.52
0.86%
-5.94
Handel nachbörslich:
687.52
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$693.46
Offen:
$673.61
24-Stunden-Volumen:
2.89M
Relative Volume:
2.89
Marktkapitalisierung:
$88.38B
Einnahmen:
$359.05B
Nettoeinkommen (Verlust:
$3.30B
KGV:
26.62
EPS:
25.83
Netto-Cashflow:
$5.23B
1W Leistung:
-2.76%
1M Leistung:
-0.27%
6M Leistung:
+11.31%
1J Leistung:
+22.79%
1-Tages-Spanne:
$664.14
$688.58
1-Wochen-Bereich:
$664.14
$728.48
52-Wochen-Spanne:
$464.42
$728.48
Mckesson Corporation Stock (MCK) Company Profile
Firmenname
Mckesson Corporation
Sektor
Branche
Telefon
972-446-4800
Adresse
6555 STATE HIGHWAY 161, IRVING, TX
Vergleichen Sie MCK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
687.52 | 88.38B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
278.38 | 56.56B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
148.62 | 36.28B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
70.47 | 8.10B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
7.15 | 626.70M | 10.42B | -38.77M | 323.54M | -0.51 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-04 | Fortgesetzt | Mizuho | Neutral |
| 2024-11-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | Bestätigt | Leerink Partners | Outperform |
| 2024-08-08 | Bestätigt | Mizuho | Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-07-06 | Herabstufung | Argus | Buy → Hold |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | Bestätigt | Barclays | Overweight |
| 2021-11-02 | Bestätigt | BofA Securities | Buy |
| 2021-11-02 | Bestätigt | Evercore ISI | Outperform |
| 2021-11-02 | Bestätigt | Jefferies | Buy |
| 2021-03-30 | Hochstufung | Argus | Hold → Buy |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-08-04 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-05-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-18 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-13 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-05 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-07-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-02 | Bestätigt | Mizuho | Neutral |
| 2018-01-24 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Mckesson Corporation Aktie (MCK) Neueste Nachrichten
Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today - Benzinga
TD Cowen Raises Price Target for McKesson (MCK) to $820 | MCK St - GuruFocus
McKesson projects $36.75-$37.55 EPS for fiscal 2026 with oncology and biopharma growth - MSN
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Here’s Why Baron Health Care Fund Reacquired McKesson Corporation (MCK) in Q1 - Insider Monkey
TD Cowen Adjusts Price Target on McKesson to $820 From $695, Maintains Buy Rating - marketscreener.com
McKesson stock up on encouraging 2026 profit guidance - MSN
Why McKesson Stock Bumped Modestly Higher Today - AOL.com
McKesson to Spin Off Medical-Surgical Company - MSN
McKesson Set To Spin Off Med-Surg Solutions Unit - Finimize
McKesson (MCK) Price Target Raised to $800 by B of A Securities | MCK Stock News - GuruFocus
McKesson (MCK) Price Target Raised Amid Strategic Focus Shift | MCK Stock News - GuruFocus
Jefferies raises McKesson stock target to $800; maintains buy By Investing.com - Investing.com South Africa
McKesson’s Earnings Call: Record Growth Amid Challenges - TipRanks
McKesson (MCK) Stock Moves on Q4 Fiscal 2025 Earnings Report - GuruFocus
Health Care Down Sharply on Drug-Demand Fears -- Health Care Roundup - marketscreener.com
McKesson to spin-off surgical supplies business, focus on oncology - The Business Journals
McKesson's Fiscal Q4 'More Loaded Than Normal' Amid Spin-Off News, UBS Says - marketscreener.com
Jefferies raises McKesson stock target to $800; maintains buy - Investing.com
McKesson Posts 16% Annual Sales Increase; Will Divest Medical-Surgical Unit - Modern Distribution Management
Jefferies Raises Price Target on McKesson to $800 From $715, Buy Rating Kept - marketscreener.com
McKesson’s Broad-Based Growth Is Fueled by GLP-1s, Customer Win, and a Growing Specialty Portfolio - Morningstar
McKesson (NYSE:MCK) Reports US$90 Billion Sales With 66% Q4 Net Income Rise - Yahoo Finance
McKesson: Spin-Off Of Medical-Surgical Solutions Is A Positive, Strong Buy (NYSE:MCK) - Seeking Alpha
McKesson to spin off medical-surgical segment - DOTmed
McKesson Spins Off Unit To Laser In On Core Drugs - Finimize
Evercore ISI Adjusts Price Target on McKesson to $760 From $740, Maintains Outperform Rating - marketscreener.com
Baird Adjusts Price Target on McKesson to $796 From $765, Maintains Outperform Rating - marketscreener.com
Deutsche Bank Adjusts Price Target on McKesson to $740 From $692 - marketscreener.com
McKesson's (NYSE:MCK) investors will be pleased with their enviable 452% return over the last five years - Yahoo Finance
McKesson Corporation (NYSE:MCK) Q4 2025 Earnings Call Transcript - MSN
McKesson price target raised to $800 from $755 at BofA - TipRanks
McKesson Reports Strong Earnings and Strategic Plans - TipRanks
McKesson Corporation (NYSE:MCK) Q1 2025 Financial Results OverviewNews and Statistics - IndexBox
MCKESSON CORP SEC 10-K Report - TradingView
McKesson’s Transfer Pricing Suit Seeks to Bring Back Tax Breaks - Bloomberg Law News
McKesson Corp (MCK) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
McKesson Corp (MCK) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - GuruFocus
McKesson: Fiscal Q4 Earnings Snapshot - CT Insider
McKesson (MCK) Reports Strong Q4 2025 Performance, Plans Strategic Spin-Off - GuruFocus
McKesson Corporation 2025 Q4ResultsEarnings Call Presentation (NYSE:MCK) - Seeking Alpha
Earnings call transcript: McKesson Q3 2025 beats EPS forecasts, stock dips - Investing.com
McKesson (MCK) Expects Stronger 2026 Adjusted Profit, Shares Surge - GuruFocus
Here's What Key Metrics Tell Us About McKesson (MCK) Q4 Earnings - Yahoo Finance
McKesson (NYSE:MCK) Misses Q1 Revenue Estimates - Yahoo Finance
McKesson Q4 & FY25 slides: Revenue up 16%, projects 11-14% EPS growth for FY26 - Investing.com India
McKesson to spin off surgical supplies unit, forecasts strong annual profit - marketscreener.com
McKesson (MCK) Tops Q4 Earnings Estimates - Yahoo Finance
McKesson to separate Medical-Surgical Solutions segment as independent company - TipRanks
Finanzdaten der Mckesson Corporation-Aktie (MCK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.63%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):